Neurooncology Flashcards
5-ALA Stummer
increase in contrast-enhancing tumor resection (36% without ALA –> 65% with ALA)
increase in progression free survival 3 years follow-up
Stupp 2005
Stupp-Schema: 60 Gy + concomitant + adjuvant temodal
median survival 12 to 14 month
LGG Jakola 2012 + 2017
norwegian hospitals (one regions favors surgery, another watchfull waiting)
overall survaval 6 to 15 years
Temodal bei MGMT-Metylierung
RTX vs RCTX: median survaval 15 to 22 month
methyliert in 50% d.F.
Avastin Gilbert 2014
Erstdiagnose GBM
erhöht progression free survival
don´t improve overall survival
WHO Klassifikation 2021
IDH
ATRX
CDKN2A/B
1p19q
TERT(telomerase reverse transcriptase), EGFR-Amplifikation, +7/-10-Kopiezahlmutation
H3-G34, H3-K27
MGMT (methylguanin-methyl-transferase)
+/- Nekrose/Gefäßproliferation
WHO Grad 2/3: Mitotische Aktivität
cIMPACT-NOW (Consortium to inform Molecular and Practival Approached to CNS tumors)
Patchell 1998
OP + RTX (Whole brain radiation) better than OP
Simpson Klassifikation
I: excision of dural attachement + ggf. bone
II: endothermy of dural attachements
III: invaded sinus or hyperostotic bone
IV: partial removal
V: decompression
Staging AKN nach Samii
T1 intrameatal
T2 intra- und extrameatal
T3a filling CPS (cerebellopontine cistern)
T3b reaching the brain stem
T4a compressing brain stem
T4b compressing IVth ventricle
Vecht 1993
radiotherapy alone or combined with neurosurgery for single brain metastasis
Perry Protokoll 2017
> 65 jährige
40 Gy in 15 Fraktionen + konkomitanter und adjuvanter TMZ
Results:
- median overall survival unabhängig vom MGMT: 7.6 –> 9.3. months
- median progression free survival unabhängig vom MGMT: 3.9 –> 5.3 months
- median overall survival in MGMT-Methylierten: 7.7 –> 13.5 months
- median overall survival in NICHT MGMT-Methylierten:7.9 –> 10
Nordic Clinical Brain Tumour Study Group % Malmström 2012
> 60 Jahre
die hypofraktionierte, dosisreduzierte Strahlentherapie 40 Gy anstatt 60 Gy ist genauso effektiv
Compliance in 60Gy Gruppe nur 70%
NOA-08 Trial by Wick 2012
Solo Temodal = Solo Radiotherapie
> 65 Jahre
overall survival ca. 9 Monate